Search - Leibniz Institute for Prevention Research and Epidemiology

251. [BIPS Project] Pharmacoepidemiological safety study of neuroleptics and antidepressants in the area of geriatric psychiatrics

URL: /en/research/projects/detail-view.html?projID=476&cHash=2613c1f6f9a8f2ef0c8cc0c397ee5124
Date: 01-11-12

More than half of Germans aged 65 and older are treated with antipsychotics or antidepressants despite of concerns that the use of these drugs in this population is associated with an increase in…

252. [BIPS Project] PAS-study for upadacitinib

URL: /en/research/projects/detail-view.html?projID=1058&cHash=7c786a506c59206d88343acad19a145c
Date: 15-02-23

Upadacitinib (Rinvoq®) is a so-called Januskinase (JAK)-inhibitor which is approved for the treatment of chronic rheumatic diseases such as ulcerative colitis, rheumatic arthritis and atopic…

253. [BIPS Project] PAS-study for tralokinumab

URL: /en/research/projects/detail-view.html?projID=1040&cHash=61d281ea60f3f02b443b69dfb3b9577a
Date: 01-01-23

PAS-study of tralokinumab use in pregnancy Tralokinumab is a biological agent developed for the treatment of moderate to severe atopic dermatitis (AD) and is administered by subcutaneous…

254. [BIPS Project] PAS-study for solriamfetol

URL: /en/research/projects/detail-view.html?projID=939&cHash=1c6fc18afaf3d549b79439bd5e94158a
Date: 15-06-22

PASS to evaluate cardiovascular events in adult patients with obstructive sleep apnoe (OSA) treated with solriamfetol Obstructive sleep apnea (OSA) is characterized by sleep fragmentation due to…

255. [BIPS Project] PAS-study for romosozumab

URL: /en/research/projects/detail-view.html?projID=911&cHash=0e924c8617af91ae44b78e9e81da7183
Date: 01-10-20

European non-interventional post-authorization safety study related to romosozumab Osteoporosis is a disease of the skeletal system that is associated with bone loss and changes in bone…

256. [BIPS Project] PAS-study for Nocdurna® (desmopressin)

URL: /en/research/projects/detail-view.html?projID=917&cHash=f3708b280935a2f6fdb046a4bcf0808f
Date: 17-11-20

Post-authorisation safety study of nocdurna for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria: A multi-country cohort study using secondary data Nocdurna…

257. [BIPS Project] PAS-study for galcanezumab

URL: /en/research/projects/detail-view.html?projID=827&cHash=69f47eb761baaa0a1cab27c240e33036
Date: 01-03-19

Galcanezumab is a humanised monoclonal antibody against human calcitonin gene-related peptide and is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month…

258. [BIPS Project] PAS-study for Entresto® (sacubitril/valsartan)

URL: /en/research/projects/detail-view.html?projID=802&cHash=8dbc9f677411b8e8f05616aac3f934c1
Date: 01-01-19

Angiotensin II antagonists (e.g. valsartan, lorsartan) are substances that lower blood pressure and cause vasodilation by modulating the renin-angiotensin system. Besides hypertension, some…

259. [BIPS Project] PAS-study for eliglustat

URL: /en/research/projects/detail-view.html?projID=918&cHash=d876d3358dfbd42e2702cd0b2b6dc02e
Date: 30-06-21

Drug utilisation study of eliglustat for the treatment of Gaucher disease type 1 in Europe using electronic healthcare records Gaucher disease (GD) is a rare genetic disorder from the group of…

260. [BIPS Project] PAS-study for Brodalumab

URL: /en/research/projects/detail-view.html?projID=850&cHash=ca3027fc09de94936039549eef3d157e
Date: 01-10-19

"The Brodalumab assessment of hazards: A multinational safety study in electronic healthcare databases" Brodalumab (Kyntheum®) is a new monoclonal antibody for the treatment of moderate to severe…